Clinical Trials

    The COVID-19 and Cancer Consortium CCC19 Registry

    Investigator: Jun Zhang

    Study Coordinator:

    Status: Open Not Enrolling

    ClinicalTrials.gov Number: N/A

    Phone:

    Protocol Number: PRO00025477

    Description


    Cancer patients have an almost unique risk profile in this pandemic. Many patients, especially those actively on treatment, have high levels of contact with the healthcare system. Many if not all cancer patients are immunocompromised, through the immunosuppressive effects of anti-cancer drugs, supportive medications such as steroids, and the cancer itself.